Trump Plans to Link Tylenol Use During Pregnancy to Autism Risk
The Trump administration is preparing new guidance advising pregnant women to avoid using Tylenol (acetaminophen) unless they have a fever. Officials cite studies suggesting a possible link between Tylenol use during early pregnancy and higher autism risk in children. The plan also includes exploring leucovorin as a potential treatment to improve communication in some children with autism.
Contrast With Current Medical Guidelines
Current medical consensus considers Tylenol safe for pregnant women when used in moderation. The proposed warning would mark a significant shift away from long-standing health guidance. Experts caution that existing studies provide mixed and inconclusive evidence on whether prenatal acetaminophen use is linked to autism.
Reaction & Pending Evidence
Health Secretary Robert F. Kennedy Jr. is expected to lead the announcement alongside senior officials. The administration is reportedly relying on reviews from institutions like Harvard and Mount Sinai. Critics argue that any changes must be based on robust, peer-reviewed science, warning against overstating risks without definitive proof.
